No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Thymosin A1 is a peptide drug used in the treatment of oncology. It is a synthetic form of thymosin, a hormone produced naturally by the thymus gland. Thymosin A1 has been shown to have anti-tumor properties, and is used to treat a variety of cancers, including breast, lung, and ovarian cancer. It is also used to treat lymphomas and leukemias. Thymosin A1 is administered intravenously, and is usually given in combination with other drugs.
Thymosin A1 is a relatively new drug, and is still in the early stages of development. It is not yet widely available, and is only approved for use in certain countries. However, it is gaining popularity as a potential treatment for cancer, and is being studied in clinical trials.
Some companies in the Thymosin A1 market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
